Our Team

Dr. David Furman is the Director of the Stanford 1000 Immunomes Project, Chief of the Center for AI and Data Science of Aging at the Buck Institute for Research on Aging, and a Adjunct Investigator for The National Scientific and Research Council, Austral University, Buenos Aires, Argentina. Dr. Furman received his Ph.D. (summa cum laude) from University of Buenos Aires, Argentina, for his work on the identification of factors produced by tumors that enable cancer cells to escape immune attack. During his postdoctoral training at the Stanford School of Medicine, Dr. Furman focused on the application of advanced analytics to study the aging of the immune system in humans and decipher how cumulative inflammatory responses associated with aging lead to an accelerated cardiovascular aging. Dr. Furman has published dozens of scientific articles in top-tier journals such as Cell, Nature Medicine, PNAS, The Lancet, and others. 

Dr. Mark M. Davis is the Director of the Stanford Institute for Immunology, Transplantation and Infection (ITI), a Professor of Microbiology and Immunology, and a Howard Hughes Medical Institute Investigator. He received a B.A. from Johns Hopkins University and a Ph.D. from the California Institute of Technology. He was a postdoctoral fellow and staff fellow at the Laboratory of Immunology at NIH and later became a faculty member in the Department of Microbiology and Immunology at Stanford University School of Medicine, where he remains today.

Dr. Davis was the first to identify the T-cell receptor genes, which are responsible for T lymphocytes ability to "see" foreign entities. His current research focused on understanding the human immune system, from developing broad systems biology approaches to inventing new methods to help unravel the complexities of T cell responses to cancer, autoimmunity and infectious diseases.

Dr. Cornelia Dekker is a Pediatric Infectious Diseases physician who came to Stanford after a 12-year career in vaccine clinical development at Lederle Biologicals and Chiron Vaccines where she served as Vice President, Clinical Research and Medical Affairs. Dr. Dekker joined the Stanford University School of Medicine faculty in the Division of Pediatric Infectious Diseases and was named Medical Director of the Stanford-LPCH Vaccine Program in 1999. She leads the Stanford Clinical Core for NIH-sponsored studies looking at the detailed immune responses to influenza vaccines in children compared with young and elderly adults that has expanded to investigate genetic factors by also studying responses of identical and fraternal twins. Dr. Dekker is currently Chair of the HIV Vaccine Trial Network Safety Monitoring Board. In 2016, she was named Medical Director for the Stanford Clinical and Translational Research Unit.

Dr. Robert Tibshirani (FRSC) is a Professor in the Departments of Statistics and Health Research and Policy at Stanford University. He was a Professor at the University of Toronto from 1985 to 1998. His main interests are in applied statistics, biostatistics, and data mining. His most well-known contributions are the LASSO method, and Significance Analysis of Microarrays. He has also authored four well-known books in Advanced Statistical Methods: Generalized Additive Models, An Introduction to the Bootstrap, The Elements of Statistical Learning, and Introduction to Statistical Learning. His current research focuses on problems in biology and genomics, medicine, and industry. In his work, he develops statistical tools for the analysis of complex datasets, most recently in genomics and proteomics.

Dr. Maecker received a B.S. in Microbiology from Purdue University and a Ph.D. in Cancer Biology from Stanford University. He did postdoctoral work with Ronald and Shoshana Levy at Stanford, and was an Assistant Professor of Biology at Loyola University Chicago, as well as a Senior Scientist at BD Biosciences, San Jose, CA. He is currently a Professor of Microbiology and Immunology, and Director of the Human Immune Monitoring Center, at Stanford University.